-
Je něco špatně v tomto záznamu ?
Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome
L. Stárka, M. Dušková
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
00023761
Ministerstvo Zdravotnictví Ceské Republiky
NLK
Directory of Open Access Journals
od 2012
Medline Complete (EBSCOhost)
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
34137683
DOI
10.14712/23362936.2021.8
Knihovny.cz E-zdroje
- MeSH
- alopecie etiologie MeSH
- androgeny MeSH
- inzulinová rezistence * MeSH
- lidé MeSH
- syndrom polycystických ovarií * MeSH
- testosteron MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The hypothesis that the most common female endocrine disease, the polycystic ovarian syndrome (PCOS), has a male equivalent, has recently become more widely accepted. The male form of PCOS is marked by alterations in the secretion of gonadotropins, increased insulin resistance, and changes of the levels of several steroid hormones, with clinical manifestations including premature androgenic alopecia (AGA). Because these symptoms are not always found in men with genetic predispositions, knowledge of the male equivalent of PCOS needs to be supplemented by measurements of adrenal 11-oxygenated C19 steroids, particularly 11-keto-, and 11β-hydroxy-derivatives of testosterone and dihydrotestosterone, by focusing on the newly-realized role of skin as an endocrine organ, and by confirming any age-related factors in glucose metabolism disorders in such predisposed men.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21017504
- 003
- CZ-PrNML
- 005
- 20210811104037.0
- 007
- ta
- 008
- 210723s2021 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2021.8 $2 doi
- 035 __
- $a (PubMed)34137683
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Stárka, Luboslav, $d 1930- $7 jn19990209795 $u Institute of Endocrinology, Prague, Czech Republic
- 245 10
- $a Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome / $c L. Stárka, M. Dušková
- 504 __
- $a Literatura
- 520 9_
- $a The hypothesis that the most common female endocrine disease, the polycystic ovarian syndrome (PCOS), has a male equivalent, has recently become more widely accepted. The male form of PCOS is marked by alterations in the secretion of gonadotropins, increased insulin resistance, and changes of the levels of several steroid hormones, with clinical manifestations including premature androgenic alopecia (AGA). Because these symptoms are not always found in men with genetic predispositions, knowledge of the male equivalent of PCOS needs to be supplemented by measurements of adrenal 11-oxygenated C19 steroids, particularly 11-keto-, and 11β-hydroxy-derivatives of testosterone and dihydrotestosterone, by focusing on the newly-realized role of skin as an endocrine organ, and by confirming any age-related factors in glucose metabolism disorders in such predisposed men.
- 650 _2
- $a alopecie $x etiologie $7 D000505
- 650 _2
- $a androgeny $7 D000728
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a syndrom polycystických ovarií $7 D011085
- 650 _2
- $a testosteron $7 D013739
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Dušková, Michaela $7 xx0080454 $u Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 122, č. 2 (2021), s. 73-79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34137683 $y Pubmed
- 910 __
- $a ABA008 $b A 7 $c 1071 $y p $z 0
- 990 __
- $a 20210723 $b ABA008
- 991 __
- $a 20210802161519 $b ABA008
- 999 __
- $a ok $b bmc $g 1682316 $s 1137946
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 122 $c 2 $d 73-79 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- GRA __
- $a 00023761 $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $b NLK118 $a Pubmed-20210723